Regenerative Medicine and the Bioethics of Globalization, Justice and Hegemony
暫譯: 再生醫學與全球化、公正及霸權的生物倫理學

Ogbogu, Ubaka, Thaldar, Donrich, Gopalan, Nishakanthi

Regenerative Medicine and the Bioethics of Globalization, Justice and Hegemony
  • 出版商: Springer
  • 出版日期: 2025-12-11
  • 售價: $8,240
  • 貴賓價: 9.5 折 $7,828
  • 語言: 英文
  • 頁數: 289
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3032072883
  • ISBN-13: 9783032072887

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This volume examines regenerative medicine (RM) through a global bioethics lens that foregrounds the structural asymmetries, epistemic exclusions, and governance disparities shaping its development and uptake. RM refers to a range of innovative therapies, clinical interventions, and research activities aimed at repairing or replacing damaged or diseased human cells, tissues, and organs, with an emphasis on conditions currently considered incurable.

While RM is often discussed using examples, standards, and governance models from high-income countries (the so-called "Global North"), much less is documented about its realities in low- and middle-income countries (LMICs), particularly in the "Global South." These contexts are frequently overlooked in ways that understate their contributions, impose ill-fitting external frameworks, or perpetuate assumptions of absence or inactivity. Such omissions contribute to epistemic injustice, in which certain perspectives, priorities, and knowledge systems are marginalized in global health innovation.

Responding to this imbalance, the present work assembles interdisciplinary contributions from scholars and practitioners deeply engaged with RM in LMICs. It adopts a collaborative bioethics approach that does not treat ethics as an afterthought to technological progress, but as integral to how innovation is imagined, governed, and shared. The collection employs a "reconnaissance mode of inquiry" to reveal underexplored practices, governance dynamics, and normative perspectives, allowing for locally grounded accounts that resist the constraints of dominant narratives.

The chapters in the volume are organized in two parts:
- Foundational Critiques -- Analytical treatments of epistemic injustice, global asymmetries, and ethical pluralism in RM.
- National Case Studies -- Country-specific explorations of RM governance, practice, and ethics in diverse settings across Africa, Asia, and Eastern Europe.

By illuminating both the commonalities and divergences that emerge from these contexts, this book offers a richer, more inclusive account of RM and its ethical governance. It challenges the hegemony of Global North perspectives and points toward bioethical frameworks that are pluralistic, context-sensitive, and globally responsive.

商品描述(中文翻譯)

本卷通過全球生物倫理的視角探討再生醫學（RM），強調塑造其發展和應用的結構性不對稱、認識論排斥和治理差異。再生醫學指的是一系列創新療法、臨床干預和研究活動，旨在修復或替換受損或患病的人類細胞、組織和器官，特別強調目前被視為無法治癒的病症。

儘管再生醫學經常使用來自高收入國家的例子、標準和治理模型進行討論（所謂的「全球北方」），但對於低收入和中等收入國家（LMICs）中的現實記錄卻少之又少，尤其是在「全球南方」。這些背景經常被忽視，導致其貢獻被低估，施加不合適的外部框架，或延續缺失或不活動的假設。這種遺漏助長了認識論不公，某些觀點、優先事項和知識體系在全球健康創新中被邊緣化。

為了回應這種不平衡，本書匯集了來自深度參與低收入和中等收入國家再生醫學的學者和實踐者的跨學科貢獻。它採用一種協作的生物倫理學方法，將倫理視為技術進步的核心，而非事後考量，並且是創新如何被想像、治理和分享的不可或缺的一部分。該文集採用「偵查模式的探究」來揭示未被充分探索的實踐、治理動態和規範觀點，允許基於當地的敘述抵抗主導敘事的限制。

本卷的章節分為兩個部分：
- **基礎批評** -- 對再生醫學中的認識論不公、全球不對稱和倫理多元主義的分析性探討。
- **國家案例研究** -- 在非洲、亞洲和東歐不同背景下對再生醫學治理、實踐和倫理的國別特定探索。

通過揭示這些背景中出現的共同點和差異，本書提供了對再生醫學及其倫理治理更豐富、更具包容性的敘述。它挑戰了全球北方觀點的霸權，並指向多元、情境敏感和全球響應的生物倫理框架。

作者簡介

Ubaka Ogbogu is a Professor and the Katz Chair in Health Law and Science Policy in the Faculty of Law at the University of Alberta. He is the Chair of the University of Alberta's Research Ethics Board 2 and a Member of the Royal Society of Canada's College of New Scholars, Artists and Scientists. Dr. Ogbogu is a recipient of the Confederation of Alberta Faculty Associations Distinguished Academic Early Career Award. He holds a doctorate in law from the University of Toronto, a Master of Laws degree from the University of Alberta, and undergraduate degrees in law from the University of Benin, Nigeria, and the Nigerian Law School.

Dr. Ogbogu's scholarly work focuses broadly on the ethical, legal, and societal implications of novel and emerging biotechnologies and related research. His recent work engages with the global governance of regenerative medicine, highlighting issues of epistemic injustice, structural inequities, and the underrepresentation of low- and middle-income country perspectives in bioethics and innovation policy. Through this work, he examines how context-sensitive, collaborative, and pluralistic approaches to ethics can address disparities in the development and distribution of cutting-edge health technologies.
Dr. Ogbogu has served on several boards and councils with a direct focus on regenerative medicine governance and policy, including the Council of Canadian Academies Expert Panel on Somatic Gene and Engineered Cell Therapies, the Canadian Institutes of Health Research Stem Cell Oversight Committee, and the International Society for Stem Cell Research Task Force on Guidelines for Stem Cell Research and Clinical Translation.

Donrich Thaldar is a full Professor of Law at the University of KwaZulu-Natal, Durban, where he chairs the Health Law & Ethics Research Interest Group. He is currently principal investigator of an NIH-funded project that investigates the legal aspects of data science in health innovation in Africa. Professor Thaldar also has a private law practice, where he specializes in strategic litigation in reproductive law (reprolaw). Before starting his academic career in 2017, he practiced as an advocate at the Pretoria Bar. He served as legal counsel or as amicus curiae in several landmark cases in the field of reprolaw in South Africa. Some highlights are: The first case that considered the concept of 'designer children' (2016); the first case of posthumous conception (2018); the first case of gamete withdrawal from a comatose person (2020); and the first case about the enforceability of a sperm donor agreement (2021); and a successful legal challenge to the constitutionality of the statutory prohibition on non-medical preimplantation sex selection (2022).

Nishakanthi Gopalan is a Senior Lecturer at the Medical Humanities and Ethics Unit (MedHEU), Faculty of Medicine, Universiti Malaya (UM), Kuala Lumpur, Malaysia, and Programme Coordinator for the Master of Health Research Ethics (MOHRE), the first postgraduate programme in health research ethics in Southeast Asia. MOHRE was developed in collaboration with the Berman Institute of Bioethics at Johns Hopkins University through a Fogarty International Center bioethics training grant, MOHRE focuses on building regional capacity in culturally attuned health research ethics. Dr. Gopalan holds a PhD in research ethics, and her scholarship centres on bioethics, research ethics, and the governance of emerging technologies, with particular emphasis on low- and middle-income country contexts.

She serves on the Universiti Malaya Research Ethics Committee (UMREC) and the Universiti Malaya Medical Centre-Medical Research Ethics Committee (UMMC-MREC), and is an editorial board member of the Asian Bioethics Review. Her research and publications explore the ethical, legal, and social implications of emerging technologies, including stem cell research, genetic testing, artificial intelligence in healthcare, and synthetic biology.

作者簡介(中文翻譯)

Ubaka Ogbogu 是阿爾伯塔大學法學院的健康法與科學政策凱茲講座教授。他是阿爾伯塔大學研究倫理委員會 2 的主席，也是加拿大皇家學會新學者、藝術家和科學家學院的成員。Ogbogu 博士獲得了阿爾伯塔省大學教師協會卓越學術早期職業獎。他擁有多倫多大學的法學博士學位、阿爾伯塔大學的法學碩士學位，以及尼日利亞貝尼大學和尼日利亞法學院的法學學士學位。

Ogbogu 博士的學術工作廣泛關注新興生物技術及相關研究的倫理、法律和社會影響。他最近的研究涉及再生醫學的全球治理，突顯了認識論不公、結構性不平等以及低收入和中等收入國家在生物倫理和創新政策中代表性不足的問題。通過這項工作，他檢視了如何通過情境敏感、協作和多元化的倫理方法來解決尖端健康技術開發和分配中的差異。

Ogbogu 博士曾在多個專注於再生醫學治理和政策的委員會和理事會任職，包括加拿大學術院的體細胞基因和工程細胞療法專家小組、加拿大健康研究院幹細胞監督委員會，以及國際幹細胞研究學會幹細胞研究和臨床轉化指導方針工作組。

Donrich Thaldar 是南非夸祖魯-納塔爾大學的法學全職教授，並擔任健康法與倫理研究興趣小組的主席。他目前是由美國國立衛生研究院（NIH）資助的項目的主要研究者，該項目調查非洲健康創新中的數據科學法律方面。Thaldar 教授還擁有一個私人法律事務所，專門從事生殖法（reprolaw）的戰略訴訟。在2017年開始學術生涯之前，他曾在比勒陀利亞律師公會擔任律師。他在南非的多起生殖法里程碑案件中擔任法律顧問或法庭之友。其中一些亮點包括：第一起考慮「設計嬰兒」概念的案件（2016年）；第一起死後受孕的案件（2018年）；第一起從昏迷者身上提取生殖細胞的案件（2020年）；第一起關於精子捐贈協議可執行性的案件（2021年）；以及對於禁止非醫療性植入前性別選擇的法定禁令的成功法律挑戰（2022年）。

Nishakanthi Gopalan 是馬來西亞吉隆坡馬來亞大學醫學人文與倫理單位（MedHEU）的高級講師，並擔任健康研究倫理碩士課程（MOHRE）的項目協調員，該課程是東南亞首個健康研究倫理的研究生課程。MOHRE 是與約翰霍普金斯大學的伯曼生物倫理研究所合作開發的，通過福加提國際中心的生物倫理培訓獎助金，MOHRE 專注於在文化適應的健康研究倫理方面建立區域能力。Gopalan 博士擁有研究倫理的博士學位，她的學術研究集中於生物倫理、研究倫理以及新興技術的治理，特別強調低收入和中等收入國家的背景。

她擔任馬來亞大學研究倫理委員會（UMREC）和馬來亞大學醫療中心醫學研究倫理委員會（UMMC-MREC）的成員，並且是《亞洲生物倫理評論》的編輯委員會成員。她的研究和出版物探討新興技術的倫理、法律和社會影響，包括幹細胞研究、基因測試、醫療保健中的人工智慧和合成生物學。

類似商品